AlzChem Group AG

AlzChem Group AG

ACT · Deutsche Borse Xetra

AlzChem Group AG (ACT) is a Chemicals specialty company in the Basic materials sector, listed on Deutsche Borse Xetra. This page provides the complete earnings calendar, dividend schedule, and financial data for AlzChem Group AG in 2026. The next earnings report is expected on October 29, 2026.

Earnings calendar

Next earnings date

29 Oct 2026

In 69 days

EPS estimate

1.90

Revenue estimate

169.6M

Past earnings

30 Jul 2026
EPS actual
1.88 (-0.7%)
estimate 1.90
Revenue actual
176.1M (+4.7%)
estimate 168.1M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
30 Apr 2026
EPS actual
2.05
estimate 2.05
Revenue actual
171.8M (+0.5%)
estimate 171.0M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
24 Feb 2026
EPS actual
1.95
estimate 1.95
Revenue actual
161.3M (-4.8%)
estimate 169.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
29 Oct 2025
EPS actual
1.89
Revenue actual
161.1M (+0.3%)
estimate 160.6M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Beat Miss usd

Latest earnings analysis

Missed consensus on EPS, with EPS of usd 1.8826 falling 0.7% short of expectations, while revenue exceeded estimates at usd 176.07 million, 4.7% above expectations. In the prior quarter EPS met expectations and revenue came in ahead of estimates.

Dividend calendar

Next ex-dividend

Not scheduled

Next payment

Not scheduled

Dividend amount

Not available

Past dividends

Ex-dividend Payment Amount
06 May 2026 08 May 2026 2.47

EPS (Earnings Per Share)

Revenue

Dividend per share

Company profile

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany.

Sector
Basic materials
Industry
Chemicals specialty
Country
Germany
Exchange
Deutsche Borse Xetra
CEO
Andreas Niedermaier
Employees
1,541
IPO date
12 Aug 2004
ISIN
DE000A2YNT30
Website
alzchem.com

Frequently asked questions

When does AlzChem Group AG (ACT) next report earnings?

AlzChem Group AG (ACT) is scheduled to report earnings on October 29, 2026.

What was AlzChem Group AG's most recent earnings date?

AlzChem Group AG (ACT) last reported earnings on July 30, 2026.

Where is AlzChem Group AG stock listed?

AlzChem Group AG (ACT) is listed on Deutsche Borse Xetra.